Strengthening the chromatography business platform through the acquisition of 資生堂医理化テクノロジー
An M&A theme to strengthen the technology, manufacturing and sales platform for chromatography-related operations by making 資生堂医理化テクノロジー a wholly owned subsidiary and integrating China’s chromatography division and sales functions.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.